Di Yiyao, Yang Fan, Che Conglu, Xu Shenghui, Qi Ying
Respiratory Department, Affiliated Hospital of Hebei University, Baoding, Hebei, People's Republic of China.
Emergency Department II, Baoding First Central Hospital, Baoding, Hebei, People's Republic of China.
Int J Gen Med. 2025 Jun 28;18:3547-3556. doi: 10.2147/IJGM.S522251. eCollection 2025.
The coexistence of chronic obstructive pulmonary disease (COPD) and tuberculosis (TB) complicates diagnosis and treatment, increasing disease burden and mortality. The correlation between serum inflammatory factors and disease severity and prognosis in COPD patients with TB remains unclear.
This retrospective study included 200 participants treated at the Affiliated Hospital of Hebei University from December 2020 to December 2022: 80 patients with COPD and TB, 40 with COPD alone, 40 with TB alone, and 40 healthy controls. Serum levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interferon-γ (IFN-γ), soluble IL-2 receptor (sIL-2R), and C-reactive protein (CRP) were compared across groups and correlated with disease severity and prognosis in COPD patients with TB.
Serum levels of TNF-α, IL-6, IFN-γ, sIL-2R, and CRP were significantly higher in the COPD with TB group compared to all other groups (P<0.05). In this group, elevated levels of these markers were associated with increased disease severity and poorer prognosis (P<0.05). Correlation analysis showed positive associations between inflammatory cytokine levels and disease severity, and negative associations with prognosis (P<0.05).
Serum inflammatory markers may help assess disease severity and prognosis in COPD patients with TB. However, due to the observational design, causality cannot be inferred. Further prospective, multi-center studies are required to validate these findings before clinical application.
慢性阻塞性肺疾病(COPD)与结核病(TB)并存会使诊断和治疗复杂化,增加疾病负担和死亡率。COPD合并TB患者血清炎症因子与疾病严重程度及预后的相关性尚不清楚。
这项回顾性研究纳入了2020年12月至2022年12月在河北大学附属医院接受治疗的200名参与者:80例COPD合并TB患者、40例单纯COPD患者、40例单纯TB患者和40名健康对照者。比较各组血清肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、干扰素-γ(IFN-γ)、可溶性IL-2受体(sIL-2R)和C反应蛋白(CRP)水平,并分析其与COPD合并TB患者疾病严重程度和预后的相关性。
与所有其他组相比,COPD合并TB组的血清TNF-α、IL-6、IFN-γ、sIL-2R和CRP水平显著更高(P<0.05)。在该组中,这些标志物水平升高与疾病严重程度增加和预后较差相关(P<0.05)。相关性分析显示炎症细胞因子水平与疾病严重程度呈正相关,与预后呈负相关(P<0.05)。
血清炎症标志物可能有助于评估COPD合并TB患者的疾病严重程度和预后。然而,由于本研究为观察性设计,无法推断因果关系。在临床应用之前需要进一步的前瞻性、多中心研究来验证这些发现。